Fosfomycin calcium tablets

This product is a broad-spectrum antibiotic. It inhibits the early synthesis of bacterial cell walls, which leads to the death of bacteria. This product has a wide antibacterial spectrum and has a certain antibacterial effect on most Gram-positive and Gram-negative bacteria. The antibacterial spectrum of this product includes Staphylococcus aureus, Escherichia coli, Shigella, Serratia, Shigella, Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacter aerogenes.

Chemical name: (-)-(1R,2S)-(1,2-Epoxypropyl)-calcium phosphate monohydrate.

This product is white or off-white tablets.

Oral administration is suitable for the following infections caused by pathogens sensitive to fosfomycin: 1. Intestinal infections: bacterial enteritis, bacillary dysentery. 2. Urinary tract infections: cystitis, pyelonephritis, urethritis. 3. Dermatological and soft tissue infections: furunculosis, anthrax, sweat gland inflammation, lymphadenitis, folliculitis. 4. Respiratory tract infections: nasopharyngitis, tonsillitis, tracheitis, early chronic bronchitis. 5. Ophthalmology: sty, dacryocystitis. 6. Gynecology: vaginitis, cervicitis.

For oral administration, adults take 2-4 g of fosfomycin acid per day; children take 50-100 mg/kg per day based on body weight, divided into 3-4 doses.

Mainly mild gastrointestinal reactions, such as nausea, decreased appetite, upper abdominal discomfort, loose stools or mild diarrhea, etc. Generally, it does not affect the continued use of the drug. Occasionally, skin rash, eosinophilia, and elevated alanine aminotransferase may occur. No toxic reactions to the kidneys or blood system were observed.

Not yet clear.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

1. It has a synergistic effect when used in combination with beta-lactams against Staphylococcus aureus (including methicillin-resistant Staphylococcus aureus) and Pseudomonas aeruginosa. 2. It has a synergistic effect when used in combination with aminoglycosides. 3. There is no cross-resistance with other antibiotics.

Sealed and stored in a dry place. Valid for two years

Calculated as C3H7O4P 0.1g

24 months

Harbin Pharmaceutical Group Pharmaceutical Factory No.6

• Founded in:

  1994-05-20

• Address:

  No. 326, Nanzhi Road, Daowai District, Harbin, Xingye East Road, Limin Economic and Technological Development Zone, Harbin

• Tax NO.:

  912301001270449678

• Registered Funds:

  -

• Website:

  Log in to view

• Email:

  Log in to view